Use of Patient Derived Tumoroids to Model Triple Negative Breast Cancer

Poster Presented at MDIBL2021 Symposium

June 2-4, 2021

Evan Cromwell, Ph.D

Poster Synopsis

This poster was presented at MDIBL2021 Symposium: Applications of Organoid Technlogy. In collaboration with Matt Burow’s group at Tulane University and Oksana Sirenko and her team at Molecular Devices, Inc, we have demonstrated the use of the Pu·MA System 3D for assays to efficiently perform:

  • automated drug treatment of patient-derived tumoroids to study drug response
  • immunofluorescence staining of tumoroids
  • high content imaging of tumoroids within the flowchips after the assay
PFI_Poster_MDIBL_Symposium 2021

Contact Us

Protein Fluidics, Inc.

875 Cowan Road, Suite B,
Burlingame, CA 94010

+1 650 529 5080

info@proteinfluidics.com

Our Company

For Research Use Only. Not for diagnostic use. Protein Fluidics, Protein Fluidics Logo and Pu•MA System are registered trademarks of Protein Fluidics, Inc. in the United States and internationally. All rights reserved. © 2021 PROTEIN FLUIDICS, INC.